Geospatial assistive technologies: potential usability criteria identified from manual wheelchair users.

To advance knowledge of specific usability criteria for Geospatial Assistive Technologies (GATs) and manual wheelchair users, and to develop a profile and expectations for potential future users. A face-to-face cross-sectional study was conducted with 17 community-dwelling manual wheelchair users (aged 18-45 years) who use a mobile device. A semi-structured interview was conducted as follows: (1) four video clips presenting technologies related to GATs (applications on a smartphone or smart watch, augmented reality glasses, virtual reality helmet) were shown; (2) questions were asked about the perceived advantages and disadvantages of route planning prior to travel and navigation while receiving guidance in urban areas; and (3) an activity to rank fifteen defined usability criteria by importance was conducted.

Geospatial assistive technologies for wheelchair users: a scoping review of usability measures and criteria for mobile user interfaces and their potential applicability.

Wheelchair users are increasingly using route planners and navigation systems to help them get around the city. The absence of a list of usability criteria for wheelchair user-centred design and recommending geospatial assistive technologies creates uncertainty about the choices to be made by rehabilitation clinicians and geographic information systems specialists. The aim of this study was to compile such a list by identifying usability criteria from standardized questionnaires linked to user interfaces and geospatial assistive technologies (GATs).

International changes in end-of-life practices over time: a systematic review.

Background: End-of-life policies are hotly debated in many countries, with international evidence frequently used to support or oppose legal reforms. Existing reviews are limited by their focus on specific practices or selected jurisdictions. The objective is to review international time trends in end-of-life practices.

[Three types of brand name loyalty strategies set up by drug manufacturers].

The recent restructuring of the pharmaceutical industry has led to three new types of promotional strategies to build patient loyalty to brand name drugs: loyalty through rebates, patient support, and compassion programs. Loyalty through rebates seeks to keep patients on a brand name drug and prevent their switch to the generic equivalent. Loyalty through patient support provides aftersales services to help and support patients (by phone or home visits) in order to improve adherence to their treatments.